Targovax announces early signal of efficacy in ONCOS-102 trial in mesothelioma. A new therapeutic treatment option may soon be available for patients diagnosed with pleural mesothelioma. Positive results have come from a phase I/II clinical trial of ONCOS-102 led by Targovax. The company specializes in immuno-oncology therapies—treatments that work with a patient’s immune system to […]
The post Clinical Trial Recruiting 30 More Pleural Mesothelioma Patients appeared first on Mesothelioma Help Now.
from Mesothelioma Help Now https://ift.tt/2rIhTZ1
via IFTTT
Clinical Trial Recruiting 30 More Pleural Mesothelioma Patients
Reviewed by Unknown
on
May 15, 2018
Rating:
No comments: